{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:35:15Z","timestamp":1790339715061,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T00:00:00Z","timestamp":1579737600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T00:00:00Z","timestamp":1579737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s11060-020-03410-1","type":"journal-article","created":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T07:03:08Z","timestamp":1579762988000},"page":"159-169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Implantation of carmustine wafers (Gliadel\u00ae) for high-grade glioma treatment. A 9-year nationwide retrospective study"],"prefix":"10.1007","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0356-0893","authenticated-orcid":false,"given":"Charles","family":"Champeaux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joconde","family":"Weller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,23]]},"reference":[{"key":"3410_CR1","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/neuonc\/noq030","volume":"12","author":"L Bauchet","year":"2010","unstructured":"Bauchet L, Mathieu-Daud\u00e9 H, Fabbro-Peray P et al (2010) Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004. Neuro Oncol 12:725\u2013735. https:\/\/doi.org\/10.1093\/neuonc\/noq030","journal-title":"Neuro Oncol"},{"key":"3410_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11060-011-0738-7","volume":"107","author":"M Koshy","year":"2012","unstructured":"Koshy M, Villano JL, Dolecek TA et al (2012) Improved survival time trends for glioblastoma using the SEER 17 population-based registries. J Neurooncol 107:207\u2013212. https:\/\/doi.org\/10.1007\/s11060-011-0738-7","journal-title":"J Neurooncol"},{"key":"3410_CR3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"key":"3410_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-19425-7","volume-title":"Regression modeling strategies","author":"FE Harrell Jr","year":"2015","unstructured":"Harrell FE (2015) Regression modeling strategies. Springer-Verlag New York, Inc., Secaucus, NJ"},{"key":"3410_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling survival data: extending the Cox model","author":"TM Therneau","year":"2000","unstructured":"Therneau TM, Grambsch PM (2000) Modeling survival data: extending the Cox model. Springer, New York"},{"key":"3410_CR6","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2014","unstructured":"R Core Team (2014) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria"},{"key":"3410_CR7","volume-title":"RStudio: Integrated development environment for r","author":"R Studio Team","year":"2015","unstructured":"R Studio Team (2015) RStudio: Integrated development environment for r. RStudio Inc, Boston, MA"},{"key":"3410_CR8","doi-asserted-by":"publisher","first-page":"e0125620","DOI":"10.1371\/journal.pone.0125620","volume":"10","author":"SG Nicholls","year":"2015","unstructured":"Nicholls SG, Quach P, von Elm E et al (2015) The REporting of studies conducted using observational routinely-collected health data (RECORD) statement: methods for arriving at consensus and developing reporting guidelines. PLoS ONE 10:e0125620. https:\/\/doi.org\/10.1371\/journal.pone.0125620","journal-title":"PLoS ONE"},{"key":"3410_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ijnurstu.2014.09.006","volume":"52","author":"TA Lang","year":"2015","unstructured":"Lang TA, Altman DG (2015) Basic statistical reporting for articles published in biomedical journals: The \"Statistical Analyses and Methods in the Published Literature\" or the SAMPL Guidelines. Int J Nurs Studies 52:5\u20139. https:\/\/doi.org\/10.1016\/j.ijnurstu.2014.09.006","journal-title":"Int J Nurs Studies"},{"key":"3410_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canep.2018.11.004","volume":"58","author":"C Champeaux","year":"2019","unstructured":"Champeaux C, Weller J, Katsahian S (2019) Epidemiology of meningiomas. A nationwide study of surgically treated tumours on french medico-administrative data. Cancer Epidemiol 58:63\u201370. https:\/\/doi.org\/10.1016\/j.canep.2018.11.004","journal-title":"Cancer Epidemiol"},{"key":"3410_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-019-00774-9","author":"C Champeaux","year":"2019","unstructured":"Champeaux C, Weller J (2019) Long-term survival after decompressive craniectomy for malignant brain infarction: A 10-year nationwide study. Neurocrit Care. https:\/\/doi.org\/10.1007\/s12028-019-00774-9","journal-title":"Neurocrit Care"},{"key":"3410_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s11060-017-2649-8","volume":"136","author":"W Sage","year":"2018","unstructured":"Sage W, Guilfoyle M, Luney C et al (2018) Local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefit. J Neurooncol 136:273\u2013280. https:\/\/doi.org\/10.1007\/s11060-017-2649-8","journal-title":"J Neurooncol"},{"key":"3410_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.neuchi.2017.07.003","volume":"63","author":"A Roux","year":"2017","unstructured":"Roux A, Caire F, Guyotat J et al (2017) Carmustine wafer implantation for high-grade gliomas: evidence-based safety efficacy and practical recommendations from the neuro-oncology club of the french society of neurosurgery. Neurochirurgie 63:433\u2013443. https:\/\/doi.org\/10.1016\/j.neuchi.2017.07.003","journal-title":"Neurochirurgie"},{"key":"3410_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11060-017-2551-4","volume":"135","author":"A Roux","year":"2017","unstructured":"Roux A, Peeters S, Zanello M et al (2017) Extent of resection and carmustine wafer implantation safely improve survival in patients with a newly diagnosed glioblastoma: A single center experience of the current practice. J Neurooncol 135:83\u201392. https:\/\/doi.org\/10.1007\/s11060-017-2551-4","journal-title":"J Neurooncol"},{"key":"3410_CR15","doi-asserted-by":"publisher","first-page":"4545","DOI":"10.1002\/cncr.27441","volume":"118","author":"E Lechapt-Zalcman","year":"2012","unstructured":"Lechapt-Zalcman E, Levallet G, Dugu\u00e9 AE et al (2012) O(6) -methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy with concomitant and adjuvant temozolomide. Cancer 118:4545\u20134554. https:\/\/doi.org\/10.1002\/cncr.27441","journal-title":"Cancer"},{"key":"3410_CR16","doi-asserted-by":"publisher","first-page":"4783","DOI":"10.1002\/cncr.24546","volume":"115","author":"P Metellus","year":"2009","unstructured":"Metellus P, Coulibaly B, Nanni I et al (2009) Prognostic impact of o6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: A prospective patient cohort. Cancer 115:4783\u20134794. https:\/\/doi.org\/10.1002\/cncr.24546","journal-title":"Cancer"},{"key":"3410_CR17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11060-015-1724-2","volume":"122","author":"SA Chowdhary","year":"2015","unstructured":"Chowdhary SA, Ryken T, Newton HB (2015) Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: A meta-analysis. J Neurooncol 122:367\u2013382. https:\/\/doi.org\/10.1007\/s11060-015-1724-2","journal-title":"J Neurooncol"},{"key":"3410_CR18","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12957-016-0975-5","volume":"14","author":"LS Ashby","year":"2016","unstructured":"Ashby LS, Smith KA, Stea B (2016) Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: A systematic literature review. World J Surg Oncol 14:225. https:\/\/doi.org\/10.1186\/s12957-016-0975-5","journal-title":"World J Surg Oncol"},{"key":"3410_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11060-018-03065-z","volume":"142","author":"P Fabbro-Peray","year":"2019","unstructured":"Fabbro-Peray P, Zouaoui S, Darlix A et al (2019) Association of patterns of care, prognostic factors, and use of radiotherapy-temozolomide therapy with survival in patients with newly diagnosed glioblastoma: A french national population-based study. J Neurooncol 142:91\u2013101. https:\/\/doi.org\/10.1007\/s11060-018-03065-z","journal-title":"J Neurooncol"},{"key":"3410_CR20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3109\/02688697.2012.673651","volume":"26","author":"SJ Price","year":"2012","unstructured":"Price SJ, Whittle IR, Ashkan K et al (2012) NICE guidance on the use of carmustine wafers in high grade gliomas: A national study on variation in practice. Br J Neurosurg 26:331\u2013335. https:\/\/doi.org\/10.3109\/02688697.2012.673651","journal-title":"Br J Neurosurg"},{"key":"3410_CR21","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3171\/2014.9.JNS14193","volume":"122","author":"MZ Sun","year":"2015","unstructured":"Sun MZ, Oh T, Ivan ME et al (2015) Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma. J Neurosurg 122:1144\u20131150. https:\/\/doi.org\/10.3171\/2014.9.JNS14193","journal-title":"J Neurosurg"},{"key":"3410_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-019-1272-6","author":"S Katsigiannis","year":"2019","unstructured":"Katsigiannis S, Krischek B, Barleanu S et al (2019) Impact of time to initiation of radiotherapy on survival after resection of newly diagnosed glioblastoma. Radiat Oncol. https:\/\/doi.org\/10.1186\/s13014-019-1272-6","journal-title":"Radiat Oncol"},{"key":"3410_CR23","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1245\/s10434-010-1081-5","volume":"17","author":"P Menei","year":"2010","unstructured":"Menei P, Metellus P, Parot-Schinkel E et al (2010) Biodegradable carmustine wafers (gliadel) alone or in combination with chemoradiotherapy: The french experience. Ann Surg Oncol 17:1740\u20131746. https:\/\/doi.org\/10.1245\/s10434-010-1081-5","journal-title":"Ann Surg Oncol"},{"key":"3410_CR24","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1093\/neuonc\/nov126","volume":"17","author":"J Pallud","year":"2015","unstructured":"Pallud J, Audureau E, Noel G et al (2015) Long-term results of carmustine wafer implantation for newly diagnosed glioblastomas: A controlled propensity-matched analysis of a french multicenter cohort. Neuro-oncology 17:1609\u20131619. https:\/\/doi.org\/10.1093\/neuonc\/nov126","journal-title":"Neuro-oncology"},{"key":"3410_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007294.pub2","author":"MG Hart","year":"2011","unstructured":"Hart MG, Garside R, Rogers G et al (2011) Chemotherapy wafers for high grade glioma. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD007294.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"3410_CR26","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1179\/1743132815Y.0000000042","volume":"37","author":"KL Chaichana","year":"2015","unstructured":"Chaichana KL, Kone L, Bettegowda C et al (2015) Risk of surgical site infection in 401 consecutive patients with glioblastoma with and without carmustine wafer implantation. Neurol Res 37:717\u2013726. https:\/\/doi.org\/10.1179\/1743132815Y.0000000042","journal-title":"Neurol Res"},{"key":"3410_CR27","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1245\/s10434-012-2764-x","volume":"20","author":"J Duntze","year":"2013","unstructured":"Duntze J, Litr\u00e9 C-F, Eap C et al (2013) Implanted carmustine wafers followed by concomitant radiochemotherapy to treat newly diagnosed malignant gliomas: Prospective, observational, multicenter study on 92 cases. Ann Surg Oncol 20:2065\u20132072. https:\/\/doi.org\/10.1245\/s10434-012-2764-x","journal-title":"Ann Surg Oncol"},{"key":"3410_CR28","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3109\/02688697.2012.697221","volume":"26","author":"JG Barr","year":"2012","unstructured":"Barr JG, Grundy PL (2012) The effects of the NICE technology appraisal 121 (gliadel and temozolomide) on survival in high-grade glioma. Br J Neurosurg 26:818\u2013822. https:\/\/doi.org\/10.3109\/02688697.2012.697221","journal-title":"Br J Neurosurg"},{"key":"3410_CR29","doi-asserted-by":"publisher","first-page":"CNS08","DOI":"10.2217\/cns-2017-0036","volume":"7","author":"KO Lillehei","year":"2018","unstructured":"Lillehei KO, Kalkanis SN, Liau LM et al (2018) Rationale and design of the 500-patient, 3-year, and prospective vigilant ObservatIon of GlIadeL WAfer ImplaNT registry. CNS Oncol 7:CNS08. https:\/\/doi.org\/10.2217\/cns-2017-0036","journal-title":"CNS Oncol"},{"key":"3410_CR30","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.2147\/DDDT.S85943","volume":"9","author":"W-K Xing","year":"2015","unstructured":"Xing W-K, Shao C, Qi Z-y et al (2015) The role of gliadel wafers in the treatment of newly diagnosed GBM: a meta-analysis. Drug Des Devel Ther 9:3341\u20133348. https:\/\/doi.org\/10.2147\/DDDT.S85943","journal-title":"Drug Des Devel Ther"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03410-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-020-03410-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03410-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:44:11Z","timestamp":1611276251000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-020-03410-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,23]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["3410"],"URL":"https:\/\/doi.org\/10.1007\/s11060-020-03410-1","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,23]]},"assertion":[{"value":"12 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflicts of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}